Brittany Vo‐Le

Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial

Sara Costi, Laurel Morris, Katherine Kirkwood et al. · American Journal of Psychiatry · 2021 · 82 citations · Full text

Medicine, Pharmacology, Psychiatry +17

A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-d-aspartate receptor blockade in healthy veterans

Nicholas Murphy, Nithya Ramakrishnan, Bylinda Vo-Le et al. · Neuropsychopharmacology · 2020 · 25 citations · Full text

Medicine, Neuroscience, Pharmacology +17

A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSD

Marijn Lijffijt, Charles E. Green, Nicholas L. Balderston et al. · Frontiers in Psychiatry · 2019 · 20 citations · Full text

Medicine, Pharmacology, Psychiatry +15

Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV‐5500) in PTSD: A randomized, double‐blind, placebo‐controlled trial

Nithya Ramakrishnan, Marijn Lijffijt, Charles E. Green et al. · Depression and Anxiety · 2021 · 12 citations · Full text

Medicine, Neuroscience, Pharmacology +14